Hi-Tech Pharmaceuticals Files Lawsuit against MusclePharm over Racketeer Influenced and Corrupt #big #pharmaceutical #companies

Posted On Nov 13 2017 by

#hitech pharma # Hi-Tech Pharmaceuticals Files Lawsuit against MusclePharm over Racketeer Influenced and Corrupt Organizations (RICO) and Protein Spiking Allegations ATLANTA. May 12, 2016 /PRNewswire/ — Protein supplement maker Hi-Tech Pharmaceuticals, Inc. says rival MusclePharm Corp. artificially inflates the level of protein in its Arnold Schwarzenegger Series Iron Mass product and then lies to consumers about it, violating federal competition and state consumer protection laws, according to a complaint filed in Georgia federal court. The lawsuit further alleges violations of the Racketeer Influenced and Corrupt Organizations (RICO) act and protein spiking allegations involving MusclePharm Sports Nutrition’s protein supplement. This lawsuit …


Editorial: State s case against Perdue Pharma deserves full hearing #pharmaceutical #companies #in #canada

Posted On Nov 13 2017 by

#perdue pharma # Editorial: State’s case against Perdue Pharma deserves full hearing While the prescription pain pill epidemic that plagued this region for nearly a decade has been replaced by a heroin epidemic, a lawsuit the state filed against Perdue Pharma, the marker of OxyContin, is still pending. Ironically, an unfavorable ruling against the company regarding a deadline it missed could cost Perdue Pharma more than $1 billion. In a suit dating to when now Speaker of the House Greg Stumbo, D-Prestonsburg, was attorney general, Kentucky claims Purdue Pharma misrepresented OxyContin, resulting in a wave of addiction and increased medical …


Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #sk #pharma

Posted On Nov 9 2017 by

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …


You Can – t Duct Tape Quality: FDA Issues Consent Decree against Actavis Totowa #pharma #equipment

Posted On Nov 9 2017 by

#actavis pharma manufacturing # Pharma Manufacturing You Can t Duct Tape Quality: FDA Issues Consent Decree against Actavis Totowa Submitted by pharmamanufacturing on Fri, 01/09/2009 – 12:48 In its neverending fight against both poor manufacturing practices and the manufacture and marketing of unapproved drugs, FDA has filed a Consent Decree and expects courts to prohibit Activis’ Totowa, New Jersey facility from further production. Actavis Totowa—a subsidiary of Iceland-based generics maker Actavis, Inc.—manufactures, packages, and distributes drugs from two sites in Totowa and one in Little Falls, N.J. FDA inspected Totowa’s Riverview Drive facility early in 2008 and found that the …


Editorial: State s case against Perdue Pharma deserves full hearing #csl #pharma

Posted On Sep 30 2017 by

#perdue pharma # Editorial: State’s case against Perdue Pharma deserves full hearing While the prescription pain pill epidemic that plagued this region for nearly a decade has been replaced by a heroin epidemic, a lawsuit the state filed against Perdue Pharma, the marker of OxyContin, is still pending. Ironically, an unfavorable ruling against the company regarding a deadline it missed could cost Perdue Pharma more than $1 billion. In a suit dating to when now Speaker of the House Greg Stumbo, D-Prestonsburg, was attorney general, Kentucky claims Purdue Pharma misrepresented OxyContin, resulting in a wave of addiction and increased medical …


FDA Takes Action Against KV Pharmaceutical Company #novartis #pharma #ag

Posted On Aug 30 2017 by

#kv pharma # Media Inquiries:Rita Chappelle, 301-796-4672Consumer Inquiries:888-INFO-FDA FDA Takes Action Against KV Pharmaceutical CompanyCompany Making, Marketing and Distributing Adulterated and Unapproved Drugs The FDA announced a Consent Decree of permanent injunction filed March 2, 2009, enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers from making and distributing adulterated and unapproved drugs. The injunction against KV and the other defendants, once entered by the court, will prevent them from manufacturing and shipping drugs until the firm obtains FDA approval. It will remain in place until the defendants sustain continuous compliance with FDA’s current …


Hi-Tech Pharmaceuticals Files Lawsuit against MusclePharm over Racketeer Influenced and Corrupt #pharma #clinical #trials

Posted On Aug 25 2017 by

#hitech pharma # Hi-Tech Pharmaceuticals Files Lawsuit against MusclePharm over Racketeer Influenced and Corrupt Organizations (RICO) and Protein Spiking Allegations ATLANTA. May 12, 2016 /PRNewswire/ — Protein supplement maker Hi-Tech Pharmaceuticals, Inc. says rival MusclePharm Corp. artificially inflates the level of protein in its Arnold Schwarzenegger Series Iron Mass product and then lies to consumers about it, violating federal competition and state consumer protection laws, according to a complaint filed in Georgia federal court. The lawsuit further alleges violations of the Racketeer Influenced and Corrupt Organizations (RICO) act and protein spiking allegations involving MusclePharm Sports Nutrition’s protein supplement. This lawsuit …


Editorial: State s case against Perdue Pharma deserves full hearing #spectrum #pharma

Posted On Aug 25 2017 by

#perdue pharma # Editorial: State’s case against Perdue Pharma deserves full hearing While the prescription pain pill epidemic that plagued this region for nearly a decade has been replaced by a heroin epidemic, a lawsuit the state filed against Perdue Pharma, the marker of OxyContin, is still pending. Ironically, an unfavorable ruling against the company regarding a deadline it missed could cost Perdue Pharma more than $1 billion. In a suit dating to when now Speaker of the House Greg Stumbo, D-Prestonsburg, was attorney general, Kentucky claims Purdue Pharma misrepresented OxyContin, resulting in a wave of addiction and increased medical …


FDA Takes Action Against KV Pharmaceutical Company #archimedes #pharma

Posted On Aug 19 2017 by

#kv pharma # Media Inquiries:Rita Chappelle, 301-796-4672Consumer Inquiries:888-INFO-FDA FDA Takes Action Against KV Pharmaceutical CompanyCompany Making, Marketing and Distributing Adulterated and Unapproved Drugs The FDA announced a Consent Decree of permanent injunction filed March 2, 2009, enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers from making and distributing adulterated and unapproved drugs. The injunction against KV and the other defendants, once entered by the court, will prevent them from manufacturing and shipping drugs until the firm obtains FDA approval. It will remain in place until the defendants sustain continuous compliance with FDA’s current …


FDA Takes Action Against KV Pharmaceutical Company #china #pharmaceutical #industry

Posted On Aug 11 2017 by

#kv pharma # Media Inquiries:Rita Chappelle, 301-796-4672Consumer Inquiries:888-INFO-FDA FDA Takes Action Against KV Pharmaceutical CompanyCompany Making, Marketing and Distributing Adulterated and Unapproved Drugs The FDA announced a Consent Decree of permanent injunction filed March 2, 2009, enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers from making and distributing adulterated and unapproved drugs. The injunction against KV and the other defendants, once entered by the court, will prevent them from manufacturing and shipping drugs until the firm obtains FDA approval. It will remain in place until the defendants sustain continuous compliance with FDA’s current …